Zynex Income After Taxes 2010-2024 | ZYXI
Zynex income after taxes from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
| Zynex Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2023 | $10 |
| 2022 | $17 |
| 2021 | $17 |
| 2020 | $9 |
| 2019 | $9 |
| 2018 | $10 |
| 2017 | $7 |
| 2016 | $0 |
| 2015 | $-3 |
| 2014 | $-6 |
| 2013 | $-7 |
| 2012 | $2 |
| 2011 | $2 |
| 2010 | $0 |
| 2009 | $2 |
| Zynex Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2024-09-30 | $2 |
| 2024-06-30 | $1 |
| 2024-03-31 | $0 |
| 2023-12-31 | $1 |
| 2023-09-30 | $4 |
| 2023-06-30 | $3 |
| 2023-03-31 | $2 |
| 2022-12-31 | $7 |
| 2022-09-30 | $5 |
| 2022-06-30 | $3 |
| 2022-03-31 | $1 |
| 2021-12-31 | $9 |
| 2021-09-30 | $6 |
| 2021-06-30 | $3 |
| 2021-03-31 | $-1 |
| 2020-12-31 | $2 |
| 2020-09-30 | $1 |
| 2020-06-30 | $3 |
| 2020-03-31 | $3 |
| 2019-12-31 | $3 |
| 2019-09-30 | $2 |
| 2019-06-30 | $2 |
| 2019-03-31 | $2 |
| 2018-12-31 | $3 |
| 2018-09-30 | $3 |
| 2018-06-30 | $2 |
| 2018-03-31 | $2 |
| 2017-12-31 | $3 |
| 2017-09-30 | $2 |
| 2017-06-30 | $2 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| 2016-09-30 | $1 |
| 2016-06-30 | $-0 |
| 2016-03-31 | $-0 |
| 2015-12-31 | $-1 |
| 2015-09-30 | $-0 |
| 2015-06-30 | $-1 |
| 2015-03-31 | $-1 |
| 2014-12-31 | $1 |
| 2014-09-30 | $0 |
| 2014-06-30 | $-6 |
| 2014-03-31 | $-1 |
| 2013-12-31 | $-5 |
| 2013-09-30 | $-1 |
| 2013-06-30 | $-2 |
| 2013-03-31 | $-0 |
| 2012-12-31 | $0 |
| 2012-09-30 | $0 |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | $1 |
| 2011-09-30 | $1 |
| 2011-06-30 | $0 |
| 2011-03-31 | $-0 |
| 2010-12-31 | $0 |
| 2010-09-30 | $0 |
| 2010-06-30 | $0 |
| 2010-03-31 | $-0 |
| 2009-12-31 | $0 |
| 2009-09-30 | $0 |
| 2009-06-30 | $1 |
| 2009-03-31 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.250B | $0.184B |
| Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $221.889B | 27.39 |
| Boston Scientific (BSX) | United States | $150.861B | 43.37 |
| Stryker (SYK) | United States | $149.166B | 32.10 |
| EssilorLuxottica (ESLOY) | France | $125.458B | 0.00 |
| Medtronic (MDT) | Ireland | $116.457B | 17.30 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.799B | 0.00 |
| Agilent Technologies (A) | United States | $43.273B | 28.64 |
| Haleon (HLN) | United Kingdom | $42.868B | 27.85 |
| GE HealthCare Technologies (GEHC) | United States | $40.342B | 20.92 |
| ResMed (RMD) | United States | $34.670B | 26.72 |
| Terumo (TRUMY) | Japan | $27.627B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $25.924B | 19.84 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.795B | 13.88 |
| Insulet (PODD) | United States | $19.527B | 77.76 |
| Baxter (BAX) | United States | $16.625B | 10.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.096B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.103B | 34.34 |
| Sunny Optical Technology (SNPTF) | China | $9.976B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.961B | 40.08 |
| Demant (WILYY) | Denmark | $8.994B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.432B | 14.94 |
| ICU Medical (ICUI) | United States | $4.024B | 38.31 |
| Prestige Consumer Healthcare (PBH) | United States | $3.793B | 18.86 |
| Envista Holdings (NVST) | United States | $3.531B | 26.31 |
| Haemonetics (HAE) | United States | $3.468B | 16.92 |
| Perrigo (PRGO) | Ireland | $3.398B | 10.00 |
| GN Store Nord (GNNDY) | Denmark | $3.105B | 19.91 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.923B | 18.81 |
| Neogen (NEOG) | United States | $2.486B | 28.65 |
| LeMaitre Vascular (LMAT) | United States | $2.179B | 52.97 |
| AtriCure (ATRC) | United States | $1.944B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.483B | 25.96 |
| AdaptHealth (AHCO) | United States | $1.456B | 10.40 |
| InMode (INMD) | Israel | $1.445B | 8.69 |
| BioLife Solutions (BLFS) | United States | $1.267B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.245B | 0.00 |
| Owens & Minor (OMI) | United States | $1.098B | 8.58 |
| Evolus (EOLS) | United States | $0.885B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.883B | 15.58 |
| Curaleaf Holdings (CURLF) | Canada | $0.866B | 0.00 |
| CeriBell (CBLL) | United States | $0.824B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.684B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.567B | 24.98 |
| Omeros (OMER) | United States | $0.500B | 0.00 |
| Surmodics (SRDX) | United States | $0.487B | 0.00 |
| Valneva SE (VALN) | France | $0.470B | 0.00 |
| SNDL (SNDL) | Canada | $0.457B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.454B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.449B | 0.00 |
| ZimVie (ZIMV) | United States | $0.382B | 32.19 |
| Quanterix (QTRX) | United States | $0.354B | 0.00 |
| Cerus (CERS) | United States | $0.347B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.319B | 30.33 |
| Sanara MedTech (SMTI) | United States | $0.318B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.300B | 20.10 |
| Biote (BTMD) | United States | $0.277B | 6.06 |
| Canopy Growth (CGC) | Canada | $0.260B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.237B | 3.33 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.226B | 0.00 |
| High Tide (HITI) | Canada | $0.226B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.208B | 15.50 |
| Aurora Cannabis (ACB) | Canada | $0.200B | 0.00 |
| Brainsway (BWAY) | Israel | $0.198B | 105.10 |
| Organigram Holdings (OGI) | Canada | $0.189B | 0.00 |
| MacroGenics (MGNX) | United States | $0.188B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.168B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.156B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.141B | 17.76 |
| Quipt Home Medical (QIPT) | United States | $0.139B | 0.00 |
| Jin Medical (ZJYL) | China | $0.138B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 11.25 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Veru (VERU) | United States | $0.081B | 0.00 |
| InterCure (INCR) | Israel | $0.074B | 0.00 |
| Exagen (XGN) | United States | $0.071B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.066B | 34.00 |
| Jushi Holdings (JUSHF) | United States | $0.065B | 0.00 |
| INLIF (INLF) | $0.062B | 0.00 | |
| Ayr Wellness (AYRWF) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| United-Guardian (UG) | United States | $0.053B | 15.18 |
| Modular Medical (MODD) | United States | $0.052B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| Sharps Technology (STSS) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |